Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies;Uticaj izvora matičnih ćelija hematopoeze na ishod alogene transplantacije u lečenju hematoloških maligniteta

Vojnosanitetski Pregled

Volumn 68, Issue 12, 2011, Pages 1026-1032

  Stamatović, Dragana ^a   Balint, Bela ^a   Tukić, Ljiljana ^a   Elez, Marija ^a   Tarabar, Olivera ^a   Todorović, Milena ^a   Ostojić, Gordana ^a   Tatomirović, Zeljka ^b   Ljubenov, Marika ^a   Marjanović, Slobodan ^a   Malešević, Milomir ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Blood; Bone marrow; Hematologic neoplasms; Hematopoietic stem cell transplantation; Homologous; Therapeutics; Transplantation; Treatment outcome

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ENGRAFTMENT; FEMALE; GRANULOCYTIC SARCOMA; HEALTH CARE COST; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; RECIPIENT; SCHOOL CHILD; SURGICAL MORTALITY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 82955165146     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1112026S     Document Type: Article

References (25)

1. Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000; 25(1): 85-9.
2. Gratwohl A, Baldomero H, Schwendener A, Rocha U, Apperley J, Frauendorfer K, et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43(4): 275-91.
3. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88(7): 2794-800.
4. Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, et al. Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant 1997; 19(5): 455-60.
5. Vigorito AC, Azevedo WM, Marques JF, Azevedo AM, Eid KA, Aranha FJ, et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998; 22(12): 1145-51.
6. Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A, et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100(3): 761-7.
7. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23(22): 5074-87.
8. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95(12): 3702-9.
9. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19(16): 3685-91.
10. Koca E, Champlin RE. Peripheral blood progenitor cell or bone marrow transplantation: controversy remains. Curr Opin Oncol 2008; 20(2): 220-6.
11. Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo D, et al. Long-term outcome of patients given transplants of mobilized blood of bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006; 108(13): 4288-90.
12. Ringden O, Labopin M, Bacigalupo A, Arcese W, Schaefer UW, Willemze R, et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002; 20(24): 4655-64.
13. Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002; 100(5): 1525-31.
14. Guardiola P, Runde V, Bacigalupo A, Ruutu T, Locatelli F, Boogaerts MA, et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 2002; 99(12): 4370-8.
15. Gallardo P, de la Camara R, Nieto JB, Espigado I, Iriondo A, Jimenez-Velasco A, et al. Is mobilized peripheral blood comparable with bone marrow as source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study. Haematologica 2009; 94(9): 1282-8.
16. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314(12): 729-35.
17. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15(6): 825-8.
18. Körbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cell matter? Blood 2001; 98(10): 2900-8.
19. Körbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86(7): 2842-8.
20. Lane TA, Ho AD, Bashey A, Peterson S, Young D, Law P. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage-and granulocyte-colony-stimulating factors. Transfusion 1999; 39(1): 39-47.
21. Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Bone Marrow Transplant 1998; 22(12): 1129-35.
22. Powles R, Mehta J, Kulkarni S, Treleaven J, Millar B, Marsden J, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet 2000; 355(9211): 1231-7.
23. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344(3): 175-81.
24. Eapen M. Peripheral blood stem cell s versus bone marrow for ablative transplantation. Biol Blood Marrow Transplant 2007; 13 (Suppl 1): 76-7.
25. Pidala J, Anasetti C, Kharfan-Dabaja MA, Cutler C, Sheldon A, Djulbegovic B. Decision analysis of peripheral blood versus bone marrow hematopoietic stem cell for alogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2009; 15(11): 1415-21.